Recruiting
Antibiotic Prophylaxis in Patients Undergoing GVO
We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.
ClinicalTrials.gov IDNCT04140578
PhasePHASE4
Enrollment150
SponsorTaipei Veterans General Hospital, Taiwan
Age20 Years
SexALL
Conditions studied
Gastric Varix, Sepsis, Liver Cirrhoses, Fever
About this study
We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.
Interventions
- Drug: Ertapenem — inject from iv drip before endoscopic cyanoacrylateinjection obliteration
Primary outcomes
- Prevetion of sepsis (3 years)
Eligibility information
Inclusion Criteria:
1. Patients with live cirrhosis and/or hepatoma
2. Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV
Exclusion Criteria:
1. Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD
2. Patients recieve antibiotics recently.
3. Patients suspected infection.
Study locations
- Veteran General Hospital-Taipei, Taipei, Taiwan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.